82
Participants
Start Date
February 28, 2015
Primary Completion Date
April 7, 2017
Study Completion Date
April 7, 2017
Pemetrexed
Carboplatin
demcizumab
The Kinghorn Cancer Centre, Darlinghurst
Ziekenhuisnetwerk Antwerpen- Koningin Paola Kinderzickenhuis, Antwerp
Chris O'Brien Lifehouse, Camperdown
North Coast Cancer Institute Port Macquarie Base Hospital, Port Macquarie
Monash Health, Monash Cancer Centre-Moorabbin, Bentleigh East
CHR de Ia Citadelle, Liège
Royall Brisbane & Women's Hospital, Herston
Icon Cancer Foundation, Milton
The Queen Elizabeth Hospital, Woodville South
Grand Hopital de Charleroi- Site Notre-Dame, Charleroi
St. John of God Subiaco Hospital, Subiaco
Centre Hospitalier Jolimont-Lobbes, La Louvière
Azienda Ospedaliera Città della Salute e della Scienza di Torino, Turin
Hematology Oncology Associates of Rockland, Nyack
Broome Oncology, LLC, Binghamton
Roswell Park Cancer Institute, Buffalo
Anne Arundel Medical Center, Annapolis
Azienda Ospedaliera Istituti Ospitalieri, Cremona
Hospital General Universitario Gregorio Marañon, Madrid
Hospital Clinico San Carlos, Madrid
Hospital Madrid Universitario Sanchinarro, Madrid
Gaston Hematology & Oncology, Gastonia
Hospital Puerta de Hierro Majadahonda, Majadahonda
Smilow Cancer Hospital at Yale-New Haven, Aviano
Ocala Oncology Center, Ocala
Hospital Universitario Virgen del Rocio, Seville
University Hospitals of Cleveland, Cleveland
Gabrail Cancer Center Research, Canton
Henry Ford Health System, Detroit
Azienda Ospedaliero Universitaria Pisana, Pisa
Edward H. Kaplan MD & Associates, Skokie
Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas
University of Texas Medical Branch at Galveston, Galveston
Desert Hematology Oncology Medical Group, Inc., Rancho Mirage
Compass Oncology, Vancouver
University of California, San Francisco, San Francisco
Smilow Cancer Hospital at Yale-New Haven, New Haven
Karmanos Cancer Institute, Detroit
Texas Oncology-Sherman, Sherman
Hospital Universitari Germans Trias i Pujol, Badalona
Hospital Universitari Germans Trias i Pujol, Barcelona
Hospital Nuestra Senora de Sonsoles, Ávila
Hospital Universitari Vall D'Hebron, Barcelona
Hospital Clinic de Barcelona, Barcelona
Institute Catalan de Oncologia (ICO L'Hospitalet), Barcelona
Lead Sponsor
Collaborators (1)
Celgene Corporation
INDUSTRY
OncoMed Pharmaceuticals, Inc.
INDUSTRY